Niagen Bioscience, Inc. (FRA:OCD1)

Niagen Bioscience Revenue

Niagen Bioscience had revenue of $33.99M USD in the quarter ending September 30, 2025, with 32.86% growth. This brings the company's revenue in the last twelve months to $124.71M, up 36.04% year-over-year. In the year 2024, Niagen Bioscience had annual revenue of $99.60M with 19.18% growth.

• Revenue (ttm): $124.71M
• Revenue Growth: +36.04%
• P/S Ratio: 3.80
• Revenue / Employee: $1.20M
• Employees: 104
• Market Cap: 403.79M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	99.60M	16.03M	19.18%
Dec 31, 2023	83.57M	11.52M	15.99%
Dec 31, 2022	72.05M	4.60M	6.82%
Dec 31, 2021	67.45M	8.19M	13.82%
Dec 31, 2020	59.26M	12.97M	28.01%
Dec 31, 2019	46.29M	14.73M	46.69%
Dec 31, 2018	31.56M	10.36M	48.85%
Dec 30, 2017	21.20M	-463.65K	-2.14%
Dec 31, 2016	21.66M	3.78M	21.13%
Jan 2, 2016	17.88M	2.57M	16.79%
Jan 3, 2015	15.31M	5.15M	50.71%
Dec 28, 2013	10.16M	-1.45M	-12.48%
Dec 29, 2012	11.61M	3.50M	43.12%
Dec 31, 2011	8.11M	546.24K	7.22%
Jan 1, 2011	7.57M	1.79M	30.95%
Jan 2, 2010	5.78M	1.27M	28.22%
Jan 3, 2009	4.51M	-247.77K	-5.21%
Dec 29, 2007	4.75M	-	-